Medtronic concludes CathWorks’ acquisition for $585m

Medtronic has completed the acquisition of CathWorks, a institution specialising successful advancing the diagnosis and attraction of coronary artery illness (CAD), for $585m, with further undisclosed earn-out payments imaginable aft the deal.

The acquisition expands Medtronic's cardiovascular illness merchandise portfolio.

In February 2026, the institution announced its volition to get CathWorks.

The determination follows a 2022 strategical concern and co-promotion statement for the CathWorks FFRangio system, presently disposable commercially successful Europe, Japan and the US.

The FFRangio System uses AI and computational subject for the physiological appraisal of the coronary arteries.

The latest announcement follows one-year results from CathWorks' ALL-RISE randomised power trial, shared astatine the 2026 American College of Cardiology conference.

This proceedings enrolled much than 1,900 patients astatine 59 sites spanning Asia, Europe, the Middle East, and North America.

Medtronic stated that the acquisition aligns with its strategy to beforehand its presumption done targeted mergers and acquisitions and to supply semipermanent worth for its partners successful the healthcare sector.

It anticipates the transaction volition person minimal interaction connected its fiscal twelvemonth 2027 GAAP and adjusted net per share, with results becoming neutral oregon accretive successful consequent years.

CathWorks president and CEO Ramin Mousavi said: “With the acquisition of CathWorks by Medtronic, we are boldly redefining the aboriginal of cardiovascular care. As I bespeak connected our semipermanent partnership, I americium profoundly grateful and arrogant of what we've accomplished together.

“This woody is simply a testament to CathWorks' and Medtronic's shared commitment, vision, and relentless thrust to revolutionise the cath laboratory and present amended solutions for patients surviving with cardiovascular disease. Together, we person ushered successful a caller dawn successful cardiovascular diagnosis and diligent outcomes.”

"Medtronic concludes CathWorks’ acquisition for $585m" was primitively created and published by Medical Device Network, a GlobalData owned brand.

The accusation connected this tract has been included successful bully religion for wide informational purposes only. It is not intended to magnitude to proposal connected which you should rely, and we springiness nary representation, warranty oregon guarantee, whether explicit oregon implied arsenic to its accuracy oregon completeness. You indispensable get nonrecreational oregon specializer proposal earlier taking, oregon refraining from, immoderate enactment connected the ground of the contented connected our site.